MetaADEDB 2.0 @ LMMD
Apparent life threatening event
(UMLS:C1610642)
UMLS ID:
C1610642
MeSH ID:
N/A
Synonym(s)
1.
Apparent life threatening event
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1OndansetronFAERS: 7US FAERS
2SertralineFAERS: 6US FAERS
3IrbesartanFAERS: 5US FAERS
4AlbuterolFAERS: 4US FAERS
5DabigatranFAERS: 4US FAERS
6IbuprofenFAERS: 4US FAERS
7OlanzapineFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
8Zoledronic AcidFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
9NorgestrelFAERS: 3US FAERS
10OmeprazoleFAERS: 3US FAERS
11ParoxetineFAERS: 3US FAERS
12RivastigmineFAERS: 3OFFSIDES
US FAERS
13TemozolomideFAERS: 3OFFSIDES
US FAERS
14TramadolFAERS: 3US FAERS
15BupivacaineFAERS: 2OFFSIDES
US FAERS
16CefuroximeFAERS: 2US FAERS
17CodeineFAERS: 2US FAERS
18LevofloxacinFAERS: 2US FAERS
19LorazepamFAERS: 2US FAERS
20MoxifloxacinFAERS: 2US FAERS
21Quetiapine FumarateFAERS: 2US FAERS
22RisperidoneFAERS: 2US FAERS
23RivaroxabanFAERS: 2US FAERS
24SertralineFAERS: 2US FAERS
25etonogestrelFAERS: 2US FAERS
26posaconazoleFAERS: 2US FAERS
2717 alpha-Hydroxyprogesterone CaproateFAERS: 1US FAERS
282-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chlorideFAERS: 1US FAERS
294-AminopyridineFAERS: 1US FAERS
305-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydron;chlorideFAERS: 1US FAERS
31Amoxicillin-Potassium Clavulanate CombinationFAERS: 1US FAERS
32AripiprazoleFAERS: 1US FAERS
33AsenapineFAERS: 1US FAERS
34AtorvastatinFAERS: 1US FAERS
35BaclofenFAERS: 1US FAERS
36Bedaquiline fumarateFAERS: 1US FAERS
37CarmustineFAERS: 1US FAERS
38CeftazidimeFAERS: 1US FAERS
39CefuroximeFAERS: 1US FAERS
40CilostazolFAERS: 1US FAERS
41CiprofloxacinFAERS: 1US FAERS
42CitalopramFAERS: 1US FAERS
43ClozapineFAERS: 1US FAERS
44Deamino Arginine VasopressinFAERS: 1US FAERS
45DextromethorphanFAERS: 1US FAERS
46DinoprostoneFAERS: 1US FAERS
47DiphenhydramineFAERS: 1US FAERS
48DiphenhydramineFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
49DronedaroneFAERS: 1US FAERS
50EpinephrineFAERS: 1US FAERS
51ErtapenemFAERS: 1US FAERS
52EstradiolFAERS: 1US FAERS
53Ethinyl Estradiol-Norgestrel CombinationFAERS: 1US FAERS
54Ethylene GlycolFAERS: 1US FAERS
55EtoposideFAERS: 1US FAERS
56FinasterideFAERS: 1US FAERS
57FluconazoleFAERS: 1US FAERS
58FluoresceinFAERS: 1US FAERS
59Glatiramer AcetateFAERS: 1OFFSIDES
US FAERS
60HaloperidolFAERS: 1US FAERS
61Imatinib MesylateFAERS: 1US FAERS
62Insulin GlargineFAERS: 1US FAERS
63Insulin degludecFAERS: 1US FAERS
64ItraconazoleFAERS: 1US FAERS
65LenalidomideFAERS: 1US FAERS
66LevetiracetamFAERS: 1US FAERS
67Lisdexamfetamine DimesylateFAERS: 1US FAERS
68MeloxicamFAERS: 1US FAERS
69MetoclopramideFAERS: 1US FAERS
70MiconazoleFAERS: 1US FAERS
71MidodrineFAERS: 1US FAERS
72N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamideFAERS: 1US FAERS
73NaproxenFAERS: 1US FAERS
74NuvaRingFAERS: 1US FAERS
75OmeprazoleFAERS: 1US FAERS
76PhenytoinFAERS: 1US FAERS
77PramipexoleFAERS: 1US FAERS
78PrednisoneFAERS: 1US FAERS
79PropafenoneFAERS: 1US FAERS
80RosiglitazoneFAERS: 1US FAERS
81Rosuvastatin CalciumFAERS: 1US FAERS
82SimvastatinFAERS: 1US FAERS
83TacrolimusFAERS: 1US FAERS
84TopiramateFAERS: 1US FAERS
85TramadolFAERS: 1US FAERS
86TrihexyphenidylFAERS: 1US FAERS
87ValsartanFAERS: 1US FAERS
88VigabatrinFAERS: 1US FAERS
89Vilazodone HydrochlorideFAERS: 1US FAERS
90carbidopa, levodopa drug combinationFAERS: 1US FAERS
91montelukastFAERS: 1US FAERS
92reviparinFAERS: 1US FAERS
93BosentanOFFSIDES
94CaffeineOFFSIDES
95CytarabineOFFSIDES
96MinocyclineOFFSIDES
97MitoxantroneOFFSIDES
98PropofolOFFSIDES
99SulfanilamideOFFSIDES
100Vitamin EOFFSIDES
101drospirenone and ethinyl estradiol combinationCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.